List view / Grid view
The Parkinson’s disease market is set to triple in sales…
The Parkinson’s disease market is set to triple in sales by 2029 driven by novel biologics and delivery systems, reports GlobalData.
According to researchers, Zolgensma, made by Novartis, will lead the…
According to researchers, Zolgensma, made by Novartis, will lead the global spinal muscular atrophy market and generate billions in sales.
A new report has shown a high level of novelty…
A new report has shown a high level of novelty and diversity for the HIV first-in-class pipeline which targets drug resistance and latency reversal.
